Cargando…
Human macrophage-engineered vesicles for utilization in ovarian cancer treatment
BACKGROUND: Ovarian cancer is a deadly female malignancy with a high rate of recurrent and chemotherapy-resistant disease. Tumor-associated macrophages (TAMs) are a significant component of the tumor microenvironment and include high levels of M2-protumor macrophages that promote chemoresistance and...
Autores principales: | Schweer, David, Anand, Namrata, Anderson, Abigail, McCorkle, J. Robert, Neupane, Khaga, Nail, Alexandra N., Harvey, Brock, Hill, Kristen S., Ueland, Frederick, Richards, Christopher, Kolesar, Jill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875020/ https://www.ncbi.nlm.nih.gov/pubmed/36713536 http://dx.doi.org/10.3389/fonc.2022.1042730 |
Ejemplares similares
-
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
por: Schweer, David, et al.
Publicado: (2022) -
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021) -
Macrophage-Engineered Vesicles for Therapeutic Delivery
and Bidirectional Reprogramming of Immune Cell Polarization
por: Neupane, Khaga R., et al.
Publicado: (2021) -
Cell-Derived Vesicles for in Vitro and in Vivo Targeted
Therapeutic Delivery
por: Snell, Aaron A., et al.
Publicado: (2019) -
Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
por: Burgess, Brian T., et al.
Publicado: (2020)